Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Harmony Biosciences LLC currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This pending action is assigned to 1 distinct examiner and is being reviewed within 1 distinct art unit. This structure indicates a localized prosecution effort, where the company's current patent interests are being evaluated by a single technical expert within one specific group at the patent office.
The busiest examiner for the company is GONZALEZ, LUISALBERTO, who is responsible for 1 busiest examiner pending office action. As the company only has 1 pending office action in total, GONZALEZ, LUISALBERTO handles the entirety of the current examination workload. This concentration requires a prosecution approach that is specifically tailored to the preferences and historical patterns of this one examiner. With no other distinct examiners or art units involved, the outcome of the company's current pending matters rests solely with the findings and decisions made by GONZALEZ, LUISALBERTO.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 58.3% | +48.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17860539 | THERAPEUTIC COMBINATIONS OF DRUGS AND METHODS OF USING THEM | GONZALEZ, LUISALBERTO | 147d overdue |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17860539 | THERAPEUTIC COMBINATIONS OF DRUGS AND METHODS OF USING THEM | GONZALEZ, LUISALBERTO | 1624 | §103Other | Final Rejection | 147d overdue | Pending | Jul 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHarmony Biosciences LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Luisalberto Gonzalez has the most, with 1 of Harmony Biosciences LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.